Longitudinal Evaluation Of The First Mutant Huntingtin PET Radioligand As A Marker For mHTT Lowering Therapies For Huntington's Disease

被引：0
|
作者：
Bertoglio, D. [1 ]
Verhaeghe, J. [1 ]
De Lombaerde, S. [1 ,2 ]
Zajicek, F. [1 ]
Vasilkovska, T. [1 ]
Miranda, A. [3 ]
Gaertner, A. [4 ]
Huscher, B. [4 ]
Kakoulidou, A. [4 ]
Cardaun, I. [4 ]
Cornelius, A. [4 ]
Schwagarus, T. [4 ]
Van der Linden, A. [1 ]
Stroobants, S. [1 ,2 ]
Wang, Y. [5 ]
Skinbjerg, M. [5 ]
Dominguez, C. [5 ]
Khetarpal, V. [5 ]
Liu, L. [5 ]
Munoz-Sanjuan, I. [5 ]
Bard, J. [5 ]
Staelens, S. [1 ]
机构：
[1] Univ Antwerp, Antwerp, Belgium
[2] Antwerp Univ Hosp, Edegem, Belgium
[3] Univ Antwerp, Antwerp, Belgium
[4] Evotec SE, Hamburg, Germany
[5] CHDI Management CHDI Fdn, Los Angeles, CA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0346
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] Quantification of Mutant Huntingtin Protein (mHTT) in Human Cerebrospinal Fluid to Support Clinical Development of mHTT-Targeting Therapies in Huntington's Disease
    Schutz, Katharina
    Buehler, Alessandra
    Schick, Eginhard
    Young, Marianne Manchester
    Boak, Lauren
    Schobel, Scott A.
    Hawellek, David J.
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 23 - 24
  • [2] Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease
    Bertoglio, Daniele
    Verhaeghe, Jeroen
    Miranda, Alan
    Wyffels, Leonie
    Stroobants, Sigrid
    Mrzljak, Ladislav
    Khetarpal, Vinod
    Skinbjerg, Mette
    Liu, Longbin
    Dominguez, Celia
    Munoz-Sanjuan, Ignacio
    Bard, Jonathan
    Staelens, Steven
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (04) : 1166 - 1175
  • [3] Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
    Daniele Bertoglio
    Jeroen Verhaeghe
    Alan Miranda
    Leonie Wyffels
    Sigrid Stroobants
    Ladislav Mrzljak
    Vinod Khetarpal
    Mette Skinbjerg
    Longbin Liu
    Celia Dominguez
    Ignacio Munoz-Sanjuan
    Jonathan Bard
    Steven Staelens
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1166 - 1175
  • [4] Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice
    Caron, Nicholas S.
    Banos, Raul
    Aly, Amirah E.
    Xie, Yuanyun
    Ko, Seunghyun
    Potluri, Nalini
    Anderson, Christine
    Black, Hailey Findlay
    Anderson, Lisa M.
    Gordon, Benjamin
    Southwell, Amber L.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2022, 166
  • [5] Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression
    Bahat, Anat
    Itzhaki, Elad
    Weiss, Benjamin
    Tolmasov, Michael
    Tsoory, Michael
    Kuperman, Yael
    Brandis, Alexander
    Shurrush, Khriesto A.
    Dikstein, Rivka
    EMBO MOLECULAR MEDICINE, 2024, 16 (03) : 523 - 546
  • [6] Parallel evaluation of mutant huntingtin and neurofilament light in Huntington's disease
    Byrne, L.
    Rodrigues, F.
    Johnson, E.
    De Vita, E.
    Czech, C.
    Schobel, S.
    Scahill, R.
    Heslegrave, A.
    Zetterberg, H.
    Wild, W.
    MOVEMENT DISORDERS, 2018, 33 : S370 - S374
  • [7] Huntingtin-lowering strategies for Huntington's disease
    Barker, Roger A.
    Fujimaki, Motoki
    Rogers, Priya
    Rubinsztein, David C.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1125 - 1132
  • [8] Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
    Tabrizi, Sarah J.
    Ghosh, Rhia
    Leavitt, Blair R.
    NEURON, 2019, 101 (05) : 801 - 819
  • [9] Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington's Disease
    Valionyte, Evelina
    Yang, Yi
    Roberts, Sheridan L.
    Kelly, Jack
    Lu, Boxun
    Luo, Shouqing
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (08) : 2673 - 2691
  • [10] Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease
    Rodrigues, Filipe B.
    Byrne, Lauren M.
    Tortelli, Rosanna
    Johnson, Eileanoir B.
    Wijeratne, Peter A.
    Arridge, Marzena
    De Vita, Enrico
    Ghazaleh, Naghmeh
    Houghton, Richard
    Furby, Hannah
    Alexander, Daniel C.
    Tabrizi, Sarah J.
    Schobel, Scott
    Scahill, Rachael, I
    Heslegrave, Amanda
    Zetterberg, Henrik
    Wild, Edward J.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (574)
12345